TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
VTVT

vTv Therapeutics Inc

Healthcare · Biotechnology

30.60$ -1.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow VTVT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– -42.0% -47.1% -25.7% +10.7% -82.1% +141.0% -5.3% +3.4% -2.2% -1.1% -82.0%
– – +207.5% +38.0% -26.6% -43.3% -33.5% +133.5% -46.0% +24.1% +74.7% +36.9%
– -1,079.6% – – – -53.8% -18.0% -738.8% – – – –
– – +100.2% +23.3% -249.8% – – – +15,285.7% -18.4% -223.8% –
– +215.2% -16.3% -34.5% -91.2% +1,300.0% -70.0% +0.0% +0.0% -100.0% – –
– -149.1% +5.1% -69.9% – +3,357.1% -108.7% +0.0% +0.0% – – –
– – – – – – – – – – – –
– – -99.1% -67.3% +7,019.2% -95.4% +1,354.2% – – – – –
– -42.5% -35.1% -39.8% -165.2% +106.1% -50.8% – -118.6% +3.1% +478.8% -100.0%
– +300.0% -90.5% -36.4% +121.5% +37.7% -14.9% +38.6% -48.2% -14.2% +338.5% +47.2%
– +29,262.4% -142.1% – – – +1,463.8% +421.6% -116.8% – – +91.2%
– – – – – – – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?